Replacement of performance enhancers by propolis ethanol extract in broiler diets / Replacement of performance enhancers by propolis ethanol extract in broiler diets

The present study was carried out to evaluate the substitution of synthetic performance enhancers by ethanolic propolis extract (EPE) in the diet of broilers and their effects on performance, carcass yield, noble cuts, viscera and bed quality. A completely randomized design was used, with four treatments and six replicates each, totaling 24 experimental plots with 20 birds each. The experimental treatments were: negative control, without the inclusion of performance improvement and EPE-free; positive control, containing avilamycin performance enhancer; Inclusion of 0.1% of EPE and; Inclusion of 0.2% EPE. The analyzed data were submitted to analysis of variance and applied the SNK test at 5% probability. There was no effect of the inclusion of additives on feed intake and feed conversion in the periods from 1 to 7, 1 to 21, and from 1 to 42 days of age. Weight gain was lower in birds receiving feed with the inclusion of 0.1% EPE in the period from 1 to 7 days, not differing from the other treatments in the other evaluation periods. Carcass characteristics, cuts, and viscera and bed moisture were not influenced by the treatments used. The inclusion of ethanol extract from propolis as a performance enhancer up to 42 days of age provided similar results to the use of performance enhancers based on avilamycin, thus being an efficient substitute in poultry production.

The present study was carried out to evaluate the substitution of synthetic performance enhancers by ethanolic propolis extract (EPE) in the diet of broilers and their effects on performance, carcass yield, noble cuts, viscera and bed quality. A completely randomized design was used, with four treatments and six replicates each, totaling 24 experimental plots with 20 birds each. The experimental treatments were: negative control, without the inclusion of performance improvement and EPE-free; positive control, containing avilamycin performance enhancer; Inclusion of 0.1% of EPE and; Inclusion of 0.2% EPE. The analyzed data were submitted to analysis of variance and applied the SNK test at 5% probability. There was no effect of the inclusion of additives on feed intake and feed conversion in the periods from 1 to 7, 1 to 21, and from 1 to 42 days of age. Weight gain was lower in birds receiving feed with the inclusion of 0.1% EPE in the period from 1 to 7 days, not differing from the other treatments in the other evaluation periods. Carcass characteristics, cuts, and viscera and bed moisture were not influenced by the treatments used. The inclusion of ethanol extract from propolis as a performance enhancer up to 42 days of age provided similar results to the use of performance enhancers based on avilamycin, thus being an efficient substitute in poultry production.

Replacement of performance enhancers by propolis ethanol extract in broiler diets

The present study was carried out to evaluate the substitution of synthetic performance enhancers by ethanolic propolis extract (EPE) in the diet of broilers and their effects on performance, carcass yield, noble cuts, viscera and bed quality. A completely randomized design was used, with four treatments and six replicates each, totaling 24 experimental plots with 20 birds each. The experimental treatments were: negative control, without the inclusion of performance improvement and EPE-free; positive control, containing avilamycin performance enhancer; Inclusion of 0.1% of EPE and; Inclusion of 0.2% EPE. The analyzed data were submitted to analysis of variance and applied the SNK test at 5% probability. There was no effect of the inclusion of additives on feed intake and feed conversion in the periods from 1 to 7, 1 to 21, and from 1 to 42 days of age. Weight gain was lower in birds receiving feed with the inclusion of 0.1% EPE in the period from 1 to 7 days, not differing from the other treatments in the other evaluation periods. Carcass characteristics, cuts, and viscera and bed moisture were not influenced by the treatments used. The inclusion of ethanol extract from propolis as a performance enhancer up to 42 days of age provided similar results to the use of performance enhancers based on avilamycin, thus being an efficient substitute in poultry production.(AU)

Replacement of performance enhancers by propolis ethanol extract in broiler diets

The present study was carried out to evaluate the substitution of synthetic performance enhancers by ethanolic propolis extract (EPE) in the diet of broilers and their effects on performance, carcass yield, noble cuts, viscera and bed quality. A completely randomized design was used, with four treatments and six replicates each, totaling 24 experimental plots with 20 birds each. The experimental treatments were: negative control, without the inclusion of performance improvement and EPE-free; positivecontrol, containing avilamycin performance enhancer; Inclusion of 0.1% of EPE and; Inclusion of 0.2% EPE. The analyzed data were submitted to analysis of variance and applied the SNK test at 5% probability. There was no effect of the inclusion of additives on feed intake and feed conversion in the periods from 1 to 7, 1 to 21,and from 1 to 42 days of age. Weight gain was lower in birds receiving feed with the inclusion of 0.1% EPE in the period from 1 to 7 days, not differing from the other treatments in the other evaluation periods. Carcass characteristics, cuts, and viscera and bed moisture were not influenced by the treatments used. The inclusion of ethanol extract from propolis as a performance enhancer up to 42 days of age provided similar results to the use of performance enhancers based on avilamycin, thus being an efficient substitute in poultry production.(AU)

Application of propolis in agriculture

ABSTRACT This work carried out a literary review of the different aspects related to the use of propolis in the management of plant crops and their advances in agriculture. Propolis is a product widely known for its therapeutic capacity. Due to its antimicrobial and antioxidant properties, among other biological activities, its use has been studied in agriculture. Studies they show that the use of propolis via ethanolic propolis extract (EEP) provides beneficial effects on crops. These benefits are associated with the control of phytopathogens, postharvest preservation and conservation of fruits and vegetables and promotion of plant growth. There is evidence that benefits are the result of the propolis chemical composition that is especially rich in phenolic compounds and nutrients. In addition, the typical waxy property of propolis results in an efficient biofilm in plant tissues. There are still scarce reports showing that the use of EEP in crop management controls the presence of insects and reduces water stress in plants. Generally, studies are mainly focused on in vivo and greenhouse evaluations, requiring further research to elucidate the full potential of the use of propolis in crop management.

Standardization of resazurin use in susceptibility testing of natural products against yeasts in planktonic cells and in biofilms formation

Natural products, such as the ethanolic propolis extract (PE), have been shown to be a safe and effective therapeutic alternative for the treatment of fungal skin and nail diseases. However, the presence of the resin and the physicochemical characteristics of the extract sometimes difficult the reading and determination of breakpoints of the in vitrotests, evidencing the need for alternatives that facilitate the reading. The present study aimed to standardize the use of resazurin in tests of susceptibility of PE with planktonic yeast cells and biofilm forms. The antifungal activity of PE was determined by minimum inhibitory concentration (MIC) and we observed that, for all Candida spp. tested, the most reproducible MIC results were obtained when resazurin was placed after 24 hours of incubation and remained more 24 hourswith yeasts plus PE. For encapsulated yeasts, there was no dye reduction and color transition. Resazurin was also used for the evaluation of minimal biofilm inhibitory concentration and minimal biofilm eradication concentration and it was metabolized and reproducedthe action of PE on Candida biofilms. In addition, microdilution checkerboard plates were made with the dye, which assisted reading the result of the interaction between PE and nystatin. We observed that the resin, the color and the turbidity of the PE slightly changed the color of the resazurin in high concentrations of the extract and did not impair the reading. Therefore, the resazurin standardization tests were proven to be efficient and grounds that it should be used as an auxiliary methodology for reading and interpretation of the susceptibility tests for non-encapsulated yeasts with natural products, which form turbidity or precipitation, such as propolis.

Standardization of resazurin use in susceptibility testing of natural products against yeasts in planktonic cells and in biofilms formation

Natural products, such as the ethanolic propolis extract (PE), have been shown to be a safe and effective therapeutic alternative for the treatment of fungal skin and nail diseases. However, the presence of the resin and the physicochemical characteristics of the extract sometimes difficult the reading and determination of breakpoints of the in vitrotests, evidencing the need for alternatives that facilitate the reading. The present study aimed to standardize the use of resazurin in tests of susceptibility of PE with planktonic yeast cells and biofilm forms. The antifungal activity of PE was determined by minimum inhibitory concentration (MIC) and we observed that, for all Candida spp. tested, the most reproducible MIC results were obtained when resazurin was placed after 24 hours of incubation and remained more 24 hourswith yeasts plus PE. For encapsulated yeasts, there was no dye reduction and color transition. Resazurin was also used for the evaluation of minimal biofilm inhibitory concentration and minimal biofilm eradication concentration and it was metabolized and reproducedthe action of PE on Candida biofilms. In addition, microdilution checkerboard plates were made with the dye, which assisted reading the result of the interaction between PE and nystatin. We observed that the resin, the color and the turbidity of the PE slightly changed the color of the resazurin in high concentrations of the extract and did not impair the reading. Therefore, the resazurin standardization tests were proven to be efficient and grounds that it should be used as an auxiliary methodology for reading and interpretation of the susceptibility tests for non-encapsulated yeasts with natural products, which form turbidity or precipitation, such as propolis.(AU)

Application of propolis in agriculture

This work carried out a literary review of the different aspects related to the use of propolis in the management of plant crops and their advances in agriculture. Propolis is a product widely known for its therapeutic capacity. Due to its antimicrobial and antioxidant properties, among other biological activities, its use has been studied in agriculture. Studies they show that the use of propolis via ethanolic propolis extract (EEP) provides beneficial effects on crops. These benefits are associated with the control of phytopathogens, postharvest preservation and conservation of fruits and vegetables and promotion of plant growth. There is evidence that benefits are the result of the propolis chemical composition that is especially rich in phenolic compounds and nutrients. In addition, the typical waxy property of propolis results in an efficient biofilm in plant tissues. There are still scarce reports showing that the use of EEP in crop management controls the presence of insects and reduces water stress in plants. Generally, studies are mainly focused on in vivo and greenhouse evaluations, requiring further research to elucidate the full potential of the use of propolis in crop management.

Effect of green propolis on the productivity, nutrient utilisation, and intestinal morphology of Japanese laying quail

In this study, we evaluated the effects of dietary inclusion of ethanolic extract of green propolis (EEGP) on productivity, egg quality, nutrient utilization, and duodenal morphology of 120 Japanese laying quail. The quail were randomly distributed into five treatment groups: one group with no EEGP in the diet (control diet) and four groups with increasing EEGP levels (500, 1000, 1500, and 2000 mg EEGP/kg diet) in the diets. Excreta and diet samples were collected on day 40 and were analyzed for dry matter (DM), crude protein (CP), ether extract (EE), ash, gross energy (GE), calcium, and phosphorus to evaluate the nutrient and energy use. At the end of the study period, productive performance, egg quality, and duodenum morphology were evaluated. Duodenal sections were obtained from four birds per treatment and were processed for optical microscopy. The EEGP did not affect DM, GE utilization, apparent metabolizable energy, ash retention, feed intake, feed conversion, egg mass, egg quality, crypt depth, or villus height:crypt depth ratio in the duodenum. However, EEGP did increase laying rate, CP, EE, calcium, and phosphorus utilization, as well as villus height and absorption surface area in the duodenum when provided to birds at 1500 and 2000 mg/kg in the diet. Thus, the inclusion of EEGP at 1500 ppm in the diet of Japanese laying quail improves productivity, egg quality, nutrient utilization ability, and duodenal morphology.(AU)

Hepatoprotective and antineoplastic potencial of red propolis produced by the bees Apis mellifera in the semiarid of Rio Grande do Norte, Brazil

ABSTRACT: The objective of this study was to evaluate the hepatoprotective effect of the honey bee Apis mellifera ethanolic extract of the red propolis, obtained in four municipalities of the Rio Grande do Norte semi-arid region, through an in vitro evaluation of the antineoplastic potential in human hepatic carcinoma (HepG2) and normal cell lines (L929), and from the comet assay in hepatic cell lines (ZF-L hepatocytes) to evaluate the genoprotective potential of the extract. The hepatoprotective effect was also evaluated in vivo by the induction of chronic experimental hepatic lesions in rodents (Rattus norvegicus Berkenhout, 1769), Wistar line, by intraperitoneal administration of thioacetamide (TAA) at the dose of 0.2g/kg. The animals were distributed in the following experimental groups: G1 (control), G2 (treated with 500mg/kg ethanolic extract of propolis), G3 (treated with 500mg/kg of ethanolic extract and TAA) and G4 (treated with TAA). All rats were submitted to serum biochemical, macroscopic, histological and stereological biochemical exams of the liver. It was verified the genoprotective effect of red propolis since the mean damages promoted to DNA in cells tested with the extract were significantly lower than the mean of the positive control damage (hydrogen peroxide). The red propolis extract did not present cytotoxic activity to the tumor cells of human liver cancer, as well as to normal ones. The absence of cytotoxicity in normal cells may indicate safety in the use of the propolis extract. The results of the serum biochemical evaluation showed that the serum levels of the aminotransferase enzymes (AST) did not differ significantly between G1, G2 and G3 when compared to each other. G4 showed significant increase in levels compared to the other groups, indicating that the administration of the extract did not cause liver toxicity, as well as exerted hepatoprotective effect against the hepatic damage induced by TAA. The G3 and G4 animals developed cirrhosis, but in G3 the livers were characterized by the presence of small regenerative nodules and level with the surface of the organ, whereas in G4 the livers showed large regenerative nodules. The livers of the G1 and G2 animals presented normal histological appearance, whereas the livers of the G3 animals showed regenerative nodules surrounded by thin septa of connective tissue, and in G4 the regenerative nodules were surrounded by thick septa fibrous connective tissue. The analysis of the hepatic tissues by means of stereology showed that there was no statistical difference between the percentage of hepatocytes, sinusoids, and collagens in G1 and G2. In G3 the percentage of hepatocytes, sinusoids, and collagen did not differ significantly from the other groups. It was concluded that the ethanolic extract of the red propolis exerted a hepatoprotective effect, because it promoted in vitro reduction of the damage to the DNA of liver cells, antineoplastic activity in human hepatocellular carcinoma cell line (HepG2) and did not exert cytotoxic effect in normal cells or was able to reduce liver enzyme activity and the severity of cirrhosis induced by TAA in vivo.

RESUMO: Este estudo objetivou avaliar o efeito hepatoprotetor do extrato etanólico da própolis vermelha da abelha Apis mellifera, obtido em quatro municípios do semiárido do Rio Grande do Norte, mediante avaliação in vitro do potencial antineoplásico em linhagens de células de carcinoma hepático humano (HepG2) e em linhagens de células normais (L929), além do ensaio cometa em linhagens de células hepáticas (hepatócitos ZF-L) para avaliar o potencial genoprotetor do extrato. O efeito hepatoprotetor também foi avaliado in vivo através da indução de lesões hepática experimental crônica em roedores da espécie Rattus norvegicus (Berkenhout, 1769), linhagem Wistar, pela administração intraperitoneal de tioacetamida (TAA) na dose de 0,2g/kg. Os animais foram distribuídos nos seguintes grupos experimentais: G1 (controle), G2 (tratados com 500mg/kg de extrato etanólico da própolis), G3 (tratados com 500mg/kg de extrato etanólico e TAA) e G4 (tratados com TAA). Todos os ratos foram submetidos aos exames bioquímico sérico, anatomopatológico macroscópico, histológico e esteriológico do fígado. Foi constatado o efeito genoprotetor da própolis vermelha uma vez que as médias dos danos promovidos ao DNA em células testadas com o extrato foram significativamente inferiores à média dos danos do controle positivo (peróxido de hidrogênio). O extrato da própolis vermelha não apresentou atividade citotóxica para células tumorais de câncer de fígado humano, bem como para normais. A ausência de citotoxicidade em células normais, tal como constatado, pode indicar segurança no uso do extrato da própolis. Os resultados da avaliação bioquímica sérica demonstraram que os níveis séricos das enzimas aminotransferase (AST) não diferiram significativamente entre G1, G2 e G3, quando comparadas entre si. No G4 houve aumento significativo dos níveis em relação aos demais grupos, indicando que a administração do extrato não causou toxicidade hepática, bem como exerceu efeito hepatoprotetor frente ao dano hepático induzido pela TAA. Os animais dos G3 e G4 desenvolveram cirrose, porém no G3 os fígados caracterizaram-se pela presença de pequenos nódulos regenerativos e nivelados com a superfície do órgão, enquanto que no G4 os fígados apresentaram grandes nódulos regenerativos. Os fígados dos animais G1 e G2 apresentaram aspecto histológico normal, enquanto que os fígados dos animais do G3 apresentaram nódulos regenerativos circundados por finos septos de tecido conjuntivo, e nos do G4 os nódulos regenerativos foram circundados por espessos septos de tecido conjuntivo fibroso. A análise dos tecidos hepáticos por meio de estereologia mostrou que não houve diferença estatística entre o percentual de hepatócitos, sinusoides e colágenos nos G1 e G2. No G3 o percentual de hepatócitos, sinusoides e colágeno não diferiu significativamente dos demais grupos. Concluiu-se que o extrato etanólico da própolis vermelha exerceu efeito genoprotetor, por promover in vitro redução do dano ao DNA de células hepáticas, atividade antineoplásica em linhagem celular de carcinoma hepatocelular humano (HepG2) e não exerceu efeito citotóxico em células normais ou efeito hepatoprotetor in vivo com diminuição da gravidade da cirrose induzida por TAA.

Hepatoprotective and antineoplastic potencial of red propolis produced by the bees Apis mellifera in the semiarid of Rio Grande do Norte, Brazil / Potencial hepatoprotetor e antineoplásico da própolis vermelha produzida pela abelha Apis mellifera no semiárido do Rio Grande do Norte, Brasil

The objective of this study was to evaluate the hepatoprotective effect of the honey bee Apis mellifera ethanolic extract of the red propolis, obtained in four municipalities of the Rio Grande do Norte semi-arid region, through an in vitro evaluation of the antineoplastic potential in human hepatic carcinoma (HepG2) and normal cell lines (L929), and from the comet assay in hepatic cell lines (ZF-L hepatocytes) to evaluate the genoprotective potential of the extract. The hepatoprotective effect was also evaluated in vivo by the induction of chronic experimental hepatic lesions in rodents (Rattus norvegicus Berkenhout, 1769), Wistar line, by intraperitoneal administration of thioacetamide (TAA) at the dose of 0.2g/kg. The animals were distributed in the following experimental groups: G1 (control), G2 (treated with 500mg/kg ethanolic extract of propolis), G3 (treated with 500mg/kg of ethanolic extract and TAA) and G4 (treated with TAA). All rats were submitted to serum biochemical, macroscopic, histological and stereological biochemical exams of the liver. It was verified the genoprotective effect of red propolis since the mean damages promoted to DNA in cells tested with the extract were significantly lower than the mean of the positive control damage (hydrogen peroxide). The red propolis extract did not present cytotoxic activity to the tumor cells of human liver cancer, as well as to normal ones. The absence of cytotoxicity in normal cells may indicate safety in the use of the propolis extract. The results of the serum biochemical evaluation showed that the serum levels of the aminotransferase enzymes (AST) did not differ significantly between G1, G2 and G3 when compared to each other. G4 showed significant increase in levels compared to the other groups, indicating that the administration of the extract did not cause liver toxicity, as well as exerted hepatoprotective effect against the hepatic damage induced by TAA...(AU)

Este estudo objetivou avaliar o efeito hepatoprotetor do extrato etanólico da própolis vermelha da abelha Apis mellifera, obtido em quatro municípios do semiárido do Rio Grande do Norte, mediante avaliação in vitro do potencial antineoplásico em linhagens de células de carcinoma hepático humano (HepG2) e em linhagens de células normais (L929), além do ensaio cometa em linhagens de células hepáticas (hepatócitos ZF-L) para avaliar o potencial genoprotetor do extrato. O efeito hepatoprotetor também foi avaliado in vivo através da indução de lesões hepática experimental crônica em roedores da espécie Rattus norvegicus (Berkenhout, 1769), linhagem Wistar, pela administração intraperitoneal de tioacetamida (TAA) na dose de 0,2g/kg. Os animais foram distribuídos nos seguintes grupos experimentais: G1 (controle), G2 (tratados com 500mg/kg de extrato etanólico da própolis), G3 (tratados com 500mg/kg de extrato etanólico e TAA) e G4 (tratados com TAA). Todos os ratos foram submetidos aos exames bioquímico sérico, anatomopatológico macroscópico, histológico e esteriológico do fígado. Foi constatado o efeito genoprotetor da própolis vermelha uma vez que as médias dos danos promovidos ao DNA em células testadas com o extrato foram significativamente inferiores à média dos danos do controle positivo (peróxido de hidrogênio). O extrato da própolis vermelha não apresentou atividade citotóxica para células tumorais de câncer de fígado humano, bem como para normais. A ausência de citotoxicidade em células normais, tal como constatado, pode indicar segurança no uso do extrato da própolis. Os resultados da avaliação bioquímica sérica demonstraram que os níveis séricos das enzimas aminotransferase (AST) não diferiram significativamente entre G1, G2 e G3, quando comparadas entre si. No G4 houve aumento significativo dos níveis em relação aos demais grupos, indicando que a administração do extrato não causou toxicidade hepática, bem como exerceu efeito...(AU)

Hepatoprotective and antineoplastic potencial of red propolis produced by the bees Apis mellifera in the semiarid of Rio Grande do Norte, Brazil / Potencial hepatoprotetor e antineoplásico da própolis vermelha produzida pela abelha Apis mellifera no semiárido do Rio Grande do Norte, Brasil

The objective of this study was to evaluate the hepatoprotective effect of the honey bee Apis mellifera ethanolic extract of the red propolis, obtained in four municipalities of the Rio Grande do Norte semi-arid region, through an in vitro evaluation of the antineoplastic potential in human hepatic carcinoma (HepG2) and normal cell lines (L929), and from the comet assay in hepatic cell lines (ZF-L hepatocytes) to evaluate the genoprotective potential of the extract. The hepatoprotective effect was also evaluated in vivo by the induction of chronic experimental hepatic lesions in rodents (Rattus norvegicus Berkenhout, 1769), Wistar line, by intraperitoneal administration of thioacetamide (TAA) at the dose of 0.2g/kg. The animals were distributed in the following experimental groups: G1 (control), G2 (treated with 500mg/kg ethanolic extract of propolis), G3 (treated with 500mg/kg of ethanolic extract and TAA) and G4 (treated with TAA). All rats were submitted to serum biochemical, macroscopic, histological and stereological biochemical exams of the liver. It was verified the genoprotective effect of red propolis since the mean damages promoted to DNA in cells tested with the extract were significantly lower than the mean of the positive control damage (hydrogen peroxide). The red propolis extract did not present cytotoxic activity to the tumor cells of human liver cancer, as well as to normal ones. The absence of cytotoxicity in normal cells may indicate safety in the use of the propolis extract. The results of the serum biochemical evaluation showed that the serum levels of the aminotransferase enzymes (AST) did not differ significantly between G1, G2 and G3 when compared to each other. G4 showed significant increase in levels compared to the other groups, indicating that the administration of the extract did not cause liver toxicity, as well as exerted hepatoprotective effect against the hepatic damage induced by TAA. The G3 and G4 animals developed cirrhosis, but in G3 the livers were characterized by the presence of small regenerative nodules and level with the surface of the organ, whereas in G4 the livers showed large regenerative nodules. The livers of the G1 and G2 animals presented normal histological appearance, whereas the livers of the G3 animals showed regenerative nodules surrounded by thin septa of connective tissue, and in G4 the regenerative nodules were surrounded by thick septa fibrous connective tissue. The analysis of the hepatic tissues by means of stereology showed that there was no statistical difference between the percentage of hepatocytes, sinusoids, and collagens in G1 and G2. In G3 the percentage of hepatocytes, sinusoids, and collagen did not differ significantly from the other groups. It was concluded that the ethanolic extract of the red propolis exerted a hepatoprotective effect, because it promoted in vitro reduction of the damage to the DNA of liver cells, antineoplastic activity in human hepatocellular carcinoma cell line (HepG2) and did not exert cytotoxic effect in normal cells or was able to reduce liver enzyme activity and the severity of cirrhosis induced by TAA in vivo.(AU)

Este estudo objetivou avaliar o efeito hepatoprotetor do extrato etanólico da própolis vermelha da abelha Apis mellifera, obtido em quatro municípios do semiárido do Rio Grande do Norte, mediante avaliação in vitro do potencial antineoplásico em linhagens de células de carcinoma hepático humano (HepG2) e em linhagens de células normais (L929), além do ensaio cometa em linhagens de células hepáticas (hepatócitos ZF-L) para avaliar o potencial genoprotetor do extrato. O efeito hepatoprotetor também foi avaliado in vivo através da indução de lesões hepática experimental crônica em roedores da espécie Rattus norvegicus (Berkenhout, 1769), linhagem Wistar, pela administração intraperitoneal de tioacetamida (TAA) na dose de 0,2g/kg. Os animais foram distribuídos nos seguintes grupos experimentais: G1 (controle), G2 (tratados com 500mg/kg de extrato etanólico da própolis), G3 (tratados com 500mg/kg de extrato etanólico e TAA) e G4 (tratados com TAA). Todos os ratos foram submetidos aos exames bioquímico sérico, anatomopatológico macroscópico, histológico e esteriológico do fígado. Foi constatado o efeito genoprotetor da própolis vermelha uma vez que as médias dos danos promovidos ao DNA em células testadas com o extrato foram significativamente inferiores à média dos danos do controle positivo (peróxido de hidrogênio). O extrato da própolis vermelha não apresentou atividade citotóxica para células tumorais de câncer de fígado humano, bem como para normais. A ausência de citotoxicidade em células normais, tal como constatado, pode indicar segurança no uso do extrato da própolis. Os resultados da avaliação bioquímica sérica demonstraram que os níveis séricos das enzimas aminotransferase (AST) não diferiram significativamente entre G1, G2 e G3, quando comparadas entre si. No G4 houve aumento significativo dos níveis em relação aos demais grupos, indicando que a administração do extrato não causou toxicidade hepática, bem como exerceu efeito hepatoprotetor frente ao dano hepático induzido pela TAA. Os animais dos G3 e G4 desenvolveram cirrose, porém no G3 os fígados caracterizaram-se pela presença de pequenos nódulos regenerativos e nivelados com a superfície do órgão, enquanto que no G4 os fígados apresentaram grandes nódulos regenerativos. Os fígados dos animais G1 e G2 apresentaram aspecto histológico normal, enquanto que os fígados dos animais do G3 apresentaram nódulos regenerativos circundados por finos septos de tecido conjuntivo, e nos do G4 os nódulos regenerativos foram circundados por espessos septos de tecido conjuntivo fibroso. A análise dos tecidos hepáticos por meio de estereologia mostrou que não houve diferença estatística entre o percentual de hepatócitos, sinusoides e colágenos nos G1 e G2. No G3 o percentual de hepatócitos, sinusoides e colágeno não diferiu significativamente dos demais grupos. Concluiu-se que o extrato etanólico da própolis vermelha exerceu efeito genoprotetor, por promover in vitro redução do dano ao DNA de células hepáticas, atividade antineoplásica em linhagem celular de carcinoma hepatocelular humano (HepG2) e não exerceu efeito citotóxico em células normais ou efeito hepatoprotetor in vivo com diminuição da gravidade da cirrose induzida por TAA.(AU)

Green propolis ethanolic extract in bean plant protection against bacterial diseases / Extrato etanólico de própolis verde na proteção de feijoeiro contra bacterioses

The aim of this study was to evaluate the ethanolic extract of green propolis (EEP) in the protection of common bean plants against two main bacterial cultures, bacterial blight (Xanthomonas axonopodis pv. phaseoli) and wildfire (Pseudomonas syringae pv. tabaci). Experiments on antimicrobial activity were performed, inducing phytoalexins, defense-related enzymes, and disease severity, under concentrations of 0, 0.5, 1.0, 2.5, and 5.0%. The EEP presented antimicrobial activity on both phytobacteria, causing a decrease in their development. It has also promoted a linear accumulation of phaseolin in bean hypocotyls according to the EEP concentration used. There was a reduction in the lesion area, which was caused by bacterial blight on bean leaves treated with EEP, and local and systemic effect were observed. Polyphenoloxidase was activated with 5% EEP, reaching the maximum activation time 62.5 h after application. An increase was observed in the activity of phenylalanine ammonia-lyase in plants treated with EEP, with local and systemic effect. Results indicated the potential of EEP in the control of these diseases.(AU)

Este trabalho teve como objetivo avaliar o extrato etanólico de própolis verde (EEP) na proteção de plantas de feijoeiro contra as duas principais bacterioses da cultura, crestamento bacteriano (Xanthomonas axonopodis pv. phaseoli) e fogo selvagem (Pseudomonas syringae pv. tabaci). Foram realizados experimentos sobre atividade antimicrobiana indutora de fitoalexinas, de enzimas relacionadas à defesa, e na severidade da doença, usando as concentrações de 0, 0,5, 1,0, 2,5 e 5,0%. O EEP apresentou atividade antimicrobiana sobre ambas fitobactérias, causando uma redução em seu desenvolvimento. O EEP também promoveu um acúmulo linear de faseolina em hipocótilos de feijoeiro conforme a concentração usada. Houve uma redução na área lesionada pelo crestamento bacteriano em folhas de feijoeiro tratadas com EEP, com efeito local e sistêmico. A enzima polifenoloxidase foi ativada pelo EEP a 5%, com ponto máximo de ativação 62,5 horas após aplicação. Houve um aumento na atividade de fenilalanina amônia-liase em plantas tratadas com EEP, com efeito local e sistêmico. Os resultados indicam o potencial do EEP no controle dessas doenças.(AU)

Atividade in vitro do extrato etanólico de própolis e do digluconato de clorexidina sobre as espécies de Candida isoladas da mucosa bucal de pacientes internados em Unidade de Terapia Intensiva (UTI) / In vitro activity of ethanolic extract of propolis and chlorhexidine digluconate on Candida species isolated from the oral mucosa of patients hospitalized in the Intensive Care Unit (ICU)

Avaliou-se a atividade dos extratos de própolis e digluconato de clorexidina em Candida sp isoladas da mucosa bucal de pacientes em UTI. Foram determinadas as concentrações fungicidas mínimas (CFM) e comparadas, nas doses sub-inibitórias, à produção de exoenzimas proteinase e fosfolipase e formação de franjas. Em 72 isolados foram avaliadas a atividade antifúngica pela técnica de microdiluição em série, na “base 2”, a produção das exoenzimas proteinase e fosfolipase, e a formação de franjas, antes e após a exposição às própolis e clorexidina. Dos 72 isolados, 53 eram C. albicans, 11 C. tropicalis, quatro C. guilhermondii e quatro sugestivas de C. dubliniensis. CFM 90% do extrato de própolis foi de 5% para C. albicans, 20% C. tropicalis, 0,625% C. guilhermondii e 0,312% sugestivas de C. dubliniensis. CFM 90% da clorexidina foi de 0,0018% para C. albicans, 0,012% C. tropicalis, de 0,0018% C. guilhermondii e de 0,00375% sugestivas de C. dubliniensis. Ocorreu inibição das exoenzimas e franjas, em ambos os produtos. Apesar da inibição da clorexidina ser menor que a da própolis, seu uso diário não causa efeitos colaterais indesejáveis como manchas nos dentes e na língua, perda do paladar e sensação de queimação na mucosa bucal.

The activity of propolis extract and chlorhexidine digluconate on Candida sp isolated from oral mucosa of patients in ICU was evaluated. The minimum fungicidal concentrations (MFC) were determined, and also the production of proteinase and phospholipase exoenzymes and the fringe formation. Seventy-two isolates were used and identified by the API 20C AUX® System. The antifungal activity was evaluated by “at base 2” serial microdilution technique. Also the exoenzymes production (proteinase and phospholipase), the fringes formation, before and after being exposed to propolis and chlorhexidine, were analysed. Of 72 isolates, 53 were C. albicans, 11 C. tropicalis, four C. guilhermondii and four suggestive C. dubliniensis. The MFC 90% of propolis extract was 5% C. albicans, 20% C. tropicalis, 0.625% C. guilhermondii; and 0.312% suggestive of C. dubliniensis. MFC 90% of chlorhexidine was 0.0018% C. albicans, 0.012% C. tropicalis, 0.0018% C. guilhermondii and 0.00375% suggestive of C. dubliniensis. The inhibition of exoenzymes and fringes occurred in the both products. Although the inhibition of chlorhexidine is lower than that showed by propolis, its daily use neither cause undesirable side effects as blemishes on the teeth and tongue, nor the loss of the taste and the burning sensation in the oral mucosa.

Atividade in vitro do extrato etanólico de própolis e do digluconato de clorexidina sobre as espécies de Candida isoladas da mucosa bucal de pacientes internados em Unidade de Terapia Intensiva (UTI) / In vitro activity of ethanolic extract of propolis and chlorhexidine digluconate on Candida species isolated from the oral mucosa of patients hospitalized in the Intensive Care Unit (ICU)

Avaliou-se a atividade dos extratos de própolis e digluconato de clorexidina em Candida sp isoladas da mucosa bucal de pacientes em UTI. Foram determinadas as concentrações fungicidas mínimas (CFM) e comparadas, nas doses sub-inibitórias, à produção de exoenzimas proteinase e fosfolipase e formação de franjas. Em 72 isolados foram avaliadas a atividade antifúngica pela técnica de microdiluição em série, na “base 2”, a produção das exoenzimas proteinase e fosfolipase, e a formação de franjas, antes e após a exposição às própolis e clorexidina. Dos 72 isolados, 53 eram C. albicans, 11 C. tropicalis, quatro C. guilhermondii e quatro sugestivas de C. dubliniensis. CFM 90% do extrato de própolis foi de 5% para C. albicans, 20% C. tropicalis, 0,625% C. guilhermondii e 0,312% sugestivas de C. dubliniensis. CFM 90% da clorexidina foi de 0,0018% para C. albicans, 0,012% C. tropicalis, de 0,0018% C. guilhermondii e de 0,00375% sugestivas de C. dubliniensis. Ocorreu inibição das exoenzimas e franjas, em ambos os produtos. Apesar da inibição da clorexidina ser menor que a da própolis, seu uso diário não causa efeitos colaterais indesejáveis como manchas nos dentes e na língua, perda do paladar e sensação de queimação na mucosa bucal.(AU)

The activity of propolis extract and chlorhexidine digluconate on Candida sp isolated from oral mucosa of patients in ICU was evaluated. The minimum fungicidal concentrations (MFC) were determined, and also the production of proteinase and phospholipase exoenzymes and the fringe formation. Seventy-two isolates were used and identified by the API 20C AUX® System. The antifungal activity was evaluated by “at base 2” serial microdilution technique. Also the exoenzymes production (proteinase and phospholipase), the fringes formation, before and after being exposed to propolis and chlorhexidine, were analysed. Of 72 isolates, 53 were C. albicans, 11 C. tropicalis, four C. guilhermondii and four suggestive C. dubliniensis. The MFC 90% of propolis extract was 5% C. albicans, 20% C. tropicalis, 0.625% C. guilhermondii; and 0.312% suggestive of C. dubliniensis. MFC 90% of chlorhexidine was 0.0018% C. albicans, 0.012% C. tropicalis, 0.0018% C. guilhermondii and 0.00375% suggestive of C. dubliniensis. The inhibition of exoenzymes and fringes occurred in the both products. Although the inhibition of chlorhexidine is lower than that showed by propolis, its daily use neither cause undesirable side effects as blemishes on the teeth and tongue, nor the loss of the taste and the burning sensation in the oral mucosa.(AU)

Gas production and in vitro degradability of sheep diets containing propolis ethanolic extract / Efeito do extrato etanólico de própolis sobre a produção de gases e degradabilidade in vitro de dietas para ovinos

This study evaluated the influence of the propolis ethanolic extract (PEE) on gas production and in vitro degradability of sheep diets. Five experimental diets (treatments) were evaluated: without addition of PEE; 6 mL PEE; 12 mL PEE; 24 mL PEE and 36 mL PEE/kg concentrate. The experimental diet consisted of 50% elephant grass (Pennisetum purpureum) and 50% concentrate. There was a quadratic effect (P 0.05) for the volumes of total gas production (Vt), gases produced by the rapid degradation fractions (Vf1), and for in vitro degradability at 120 hours (Deg120), where the lowest values of Vt, Vf1 and Deg120, were found for the inclusion of 9.4 mL PEE/kg concentrate. Gas production by fermentation of the slow degradation fraction (Vf2) presented a mean of 25 mL/g DM (P 0.05). The colonization time of food particles () significantly reduced (P 0.05) with increasing inclusion of PEE. Thus, it can be concluded that the PEE up to the inclusion of 9.4 mL/kg concentrate was efficient in inhibiting in vitro total gas production and from the fractions of rapid degradation by 9.9 and 15.3%, respectively, in addition to promoting a reduction of 5.3% in degradability after 120 h incubation in diets with a concentrate: forage ratio of 50:50. Thus, the inhibition in gas production was proportionally greater than the reduction of degradability.(AU)

Objetivou-se com este estudo avaliar se a produção de gases e a degradabilidade in vitro de dietas para ovinos podem ser influenciadas pelo uso do extrato etanólico de propólis.Foram avaliados cinco níveis de inclusão do extrato etanólico de própolis (EEP) nas dietas, sendo: sem adição de EEP; 6 mL de EEP; 12 mL de EEP; 24 mL EEP e 36 mL de EEP/kg de concentrado, sendo a dieta experimental constituída de 50% de capim elefante triturado (Pennisetum purpureum) como volumoso e 50% de concentrado (milho, farelo de soja e núcleo mineral e vitamínico). Houve efeito quadrático (P 0,05) para os volumes de produção de gases total (Vt),gases produzidos pelas frações de degradação rápida (Vf1) e para a degradabilidade in vitro em 120 horas (Deg120), onde os menores valores de Vt, Vf1 e Deg120, foram encontrados para a inclusão aproximada de 9 mL de EEP/Kg de concentrado, representando, 79,85 (Vt) e 55,08 (Vf1) mL/g de MS, e 79,14% de degradabilidade. Já produção de gás pela fermentação da fração de degradação lenta (Vf2) não foi significativo (P 0,05), com média de 25 mL/g MS. O tempo de colonização das partículas do alimento () reduziu significativamente (P 0,05) com o aumento dos níveis de inclusão do EEP. Sendo assim, é possível concluir que o extrato etanólico de própolis até a inclusão de 9,4 mL/Kg de concentrado foi eficiente em inibir in vitro a produção de gases total (Vt) e a partir das frações de degradação rápida (Vf1)em 9,9 e 15,3%, respectivamente, além de promover uma redução de 5,3% na degradabilidade após 120 h de incubação (Deg120h), em dietas com proporção concentrado:volumoso de 50:50. Assim, a inibição na produção de gases foi proporcionalmente superior a redução da degradabilidade.(AU)

Gas production and in vitro degradability of sheep diets containing propolis ethanolic extract / Efeito do extrato etanólico de própolis sobre a produção de gases e degradabilidade in vitro de dietas para ovinos

This study evaluated the influence of the propolis ethanolic extract (PEE) on gas production and in vitro degradability of sheep diets. Five experimental diets (treatments) were evaluated: without addition of PEE; 6 mL PEE; 12 mL PEE; 24 mL PEE and 36 mL PEE/kg concentrate. The experimental diet consisted of 50% elephant grass (Pennisetum purpureum) and 50% concentrate. There was a quadratic effect (P 0.05) for the volumes of total gas production (Vt), gases produced by the rapid degradation fractions (Vf1), and for in vitro degradability at 120 hours (Deg120), where the lowest values of Vt, Vf1 and Deg120, were found for the inclusion of 9.4 mL PEE/kg concentrate. Gas production by fermentation of the slow degradation fraction (Vf2) presented a mean of 25 mL/g DM (P 0.05). The colonization time of food particles () significantly reduced (P 0.05) with increasing inclusion of PEE. Thus, it can be concluded that the PEE up to the inclusion of 9.4 mL/kg concentrate was efficient in inhibiting in vitro total gas production and from the fractions of rapid degradation by 9.9 and 15.3%, respectively, in addition to promoting a reduction of 5.3% in degradability after 120 h incubation in diets with a concentrate: forage ratio of 50:50. Thus, the inhibition in gas production was proportionally greater than the reduction of degradability.

Objetivou-se com este estudo avaliar se a produção de gases e a degradabilidade in vitro de dietas para ovinos podem ser influenciadas pelo uso do extrato etanólico de propólis.Foram avaliados cinco níveis de inclusão do extrato etanólico de própolis (EEP) nas dietas, sendo: sem adição de EEP; 6 mL de EEP; 12 mL de EEP; 24 mL EEP e 36 mL de EEP/kg de concentrado, sendo a dieta experimental constituída de 50% de capim elefante triturado (Pennisetum purpureum) como volumoso e 50% de concentrado (milho, farelo de soja e núcleo mineral e vitamínico). Houve efeito quadrático (P 0,05) para os volumes de produção de gases total (Vt),gases produzidos pelas frações de degradação rápida (Vf1) e para a degradabilidade in vitro em 120 horas (Deg120), onde os menores valores de Vt, Vf1 e Deg120, foram encontrados para a inclusão aproximada de 9 mL de EEP/Kg de concentrado, representando, 79,85 (Vt) e 55,08 (Vf1) mL/g de MS, e 79,14% de degradabilidade. Já produção de gás pela fermentação da fração de degradação lenta (Vf2) não foi significativo (P 0,05), com média de 25 mL/g MS. O tempo de colonização das partículas do alimento () reduziu significativamente (P 0,05) com o aumento dos níveis de inclusão do EEP. Sendo assim, é possível concluir que o extrato etanólico de própolis até a inclusão de 9,4 mL/Kg de concentrado foi eficiente em inibir in vitro a produção de gases total (Vt) e a partir das frações de degradação rápida (Vf1)em 9,9 e 15,3%, respectivamente, além de promover uma redução de 5,3% na degradabilidade após 120 h de incubação (Deg120h), em dietas com proporção concentrado:volumoso de 50:50. Assim, a inibição na produção de gases foi proporcionalmente superior a redução da degradabilidade.

Propolis extract in tshe diet of weaned piglets / Extrato de própolis na dieta de leitões desmamados

This study was conducted to assess the use of propolis ethanolic extract as an alternative to performance-enhancing antibiotics for piglets. Seventy piglets weaned at 21 days of age, with initial weights of 7.3±0.4kg and final weights of 24.9±1.2kg, were randomly assigned to five diets: positive control (diet with 200ppm antibiotic); negative control (diet without growth promoter); and diets with 100, 500, and 1,000ppm of brown propolis ethanolic extract, with seven replicates of two piglets each. The duration of the experimental period was 35 days. The diets did not influence (P>0.05) daily feed intake, daily weight gain, final weight, and feed conversion of animals. The bacteriological profile of the nasal swab presented a predominance of gram-positive bacteria commonly associated with the mucous membranes in all samples. Rectal swabs did not present atypical bacterial isolates. The use of ethanolic propolis extract in diets did not alter the performance of weaned piglets, nor did it affect the bacteriological profile, fecal score, or the occurrence of diarrhea in piglets.(AU)

Esta pesquisa foi realizada com o objetivo de investigar a utilização de extrato etanóico de própolis como alternativa aos antibióticos melhoradores de desempenho para leitões. Foram avaliados 70 leitões desmamados aos 21 dias de idade, com pesos iniciais de 7,3±0,4kg e final de 24,9±1,2kg. Estes foram distribuídos em delineamento de blocos ao acaso, com cinco dietas: controle positivo - dieta com 200ppm de antibiótico; controle negativo - dieta sem promotor de crescimento; dietas com 100, 500 e 1.000ppm de extrato etanóico de própolis marrom, com sete repetições de dois leitões cada. A duração do período experimental foi de 35 dias. As dietas não influenciaram (P>0,05) no consumo de ração diária, ganho de peso diário, peso final e a conversão alimentar dos animais. O perfil bacteriológico da swab nasal apresentou predomínio de bactérias Gram positivas comumente associadas às membranas das mucosas em todas as coletas realizadas. As swabs retais não apresentaram isolamento atípico. A utilização do extrato etanóico de própolis nas dietas não altera o desempenho de leitões desmamados, bem como não afeta o perfil bacteriológico, escore fecal e a ocorrência de diarreia dos leitões.(AU)

Isoflavone formononetin from red propolis acts as a fungicide against Candida sp

A bioassay-guided fractionation of two samples of Brazilian red propolis (from Igarassu, PE, Brazil, hereinafter propolis 1 and 2) was conducted in order to determine the components responsible for its antimicrobial activity, especially against Candida spp. Samples of both the crude powdered resin and the crude ethanolic extract of propolis from both locations inhibited the growth of all 12 tested Candida strains, with a minimum inhibitory concentration of 256 µg/mL. The hexane, acetate and methanol fractions of propolis 1 also inhibited all strains with minimum inhibitory concentration values ranging from 128 to 512 µg/mL for the six bacteria tested and from 32 to 1024 µg/mL for the yeasts. Similarly, hexane and acetate fractions of propolis sample 2 inhibited all microorganisms tested, with minimum inhibitory concentration values of 512 µg/mL for bacteria and 32 µg/mL for yeasts. The extracts were analyzed by HPLC and their phenolic profile allowed us to identify and quantitate one phenolic acid and seven flavonoids in the crude ethanolic extract. Formononetin and pinocembrin were the major constituents amongst the identified compounds. Formononetin was detected in all extracts and fractions tested, except for the methanolic fraction of sample 2. The isolated isoflavone formononetin inhibited the growth of all the microorganisms tested, with a minimum inhibitory concentration of 200 µg/mL for the six bacteria strains tested and 25 µg/mL for the six yeasts. Formononetin also exhibited fungicidal activity against five of the six yeasts tested. Taken together our results demonstrate that the isoflavone formononetin is implicated in the reported antimicrobial activity of red propolis. (AU)

POTENCIAL ANTIMICROBIANO DA PRÓPOLIS VERDE SOBRE Salmonella enterica subsp. enterica

Ao longo dos anos, diversos microrganismos adaptaram-se e adquiriram resistência aos fármacos. A resistência aos antimicrobianos é considerada um problema global para os sistemas de saúde, no âmbito humano e animal. Salmonella consta como um dos patógenos de veiculação alimentar de grande impacto para a saúde pública. A ocorrência de isolados com perfis de multirresistência é real em todos os continentes e métodos alternativos devem ser investigados. Neste contexto, o objetivo deste estudo foi avaliar o efeito antimicrobiano de extratos de própolis verde sobre Salmonella enterica, bem como determinar o teor de compostos bioativos e perfil de sensibilidade a antimicrobianos convencionais no uso terapêutico. A própolis foi submetida a dois tipos de extração, etanólica e ultrassônica, decorrendo em extratos de igual terminologia. Foram quantificados os compostos fenólicos totais, teor de flavonoides totais e atividade antioxidante total pelo radical livre DPPH. Estes extratos foram diluídos em etanol nas concentrações: 100; 50; 25; 12,5; 6,25; 3,125; 1,56; 0,8; 0,4; 0,2 e 0,1 mg/mL-1. Duas cepas referenciais e 30 isolados do gênero Salmonella procedentes de alimento avícola e do ambiente subsidiaram os ensaios de viabilidade celular pelo método de microdiluição. Analisou-se o perfil de suscetibilidade de todas as cepas para amicacina (30g), norfloxacina (10g), ceftriaxona (30g), ceftiofur (30g) e doxiciclina (30g), pelo método de disco-difusão. Os resultados evidenciaram que os isolados de campo apresentaram resistência cruzada e múltipla, sendo que 83,3% (25/30) das amostras foram resistentes a um ou mais agentes antimicrobianos utilizados, apenas cinco isolados não apresentaram resistência e 21 isolados foram multirresistentes. A resistência cruzada ocorreu em 63,3% (19/30) dos isolados frente as cefalosporinas. Em relação à ação do extrato etanólico de própolis verde, identificou-se que para os sorotipos Agona, Anatum, Cerro, Saintpaul e todas as estirpes de Schwarzengrund apresentaram respostas igualitárias quanto à concentração inibitória mínima. Para os sorovar Heidelberg observou-se variabilidade para CIM, encontrando-se concentrações de 6,25 a 25 mg/mL-1 bem como para a concentração bactericida mínima com variações entre 50 e 100 mg/mL-1. Para o extrato ultrassônico de própolis verde à CIM apresentou respostas iguais para os sorotipos Agona, Cerro e Saintpaul. Para o sorovar Heidelberg ocorreu variação para CIM entre 6,25 a 25 mg/mL-1, para o sorovar Schwarzengrund ocorreu variação entre 6,25 a 12,5 mg/mL-1. Conclui-se que isolados de campo reforçam o alerta sobre cepas multirresistentes para bases antimicrobianas eleitas para uso terapêutico no contexto da saúde animal e humana. Os extratos de própolis verde, por suas concentrações de compostos fenólicos/ flavonoides e seus componentes antioxidantes, apresentaram ação biológica antimicrobiana que inibiram, em concentrações variadas, sorotipos de Salmonella enterica oriundos do ambiente avícola. Por tais observações, pode-se considerar ambos extratos de própolis verde como alternativa dose-dependente à inibição de Salmonella.

Over the years, several microorganisms have adapted and bought resistance to drugs. Antimicrobial resistance is considered a global problem for health systems, with no human and animal scope. Salmonella consumes as one of the foodborne pathogens of great impact on public health. The occurrence of episodes with multidrug resistance is real on all continents and alternative methods should be investigated. In this context, the aim of this study was to evaluate the antimicrobial effect of green propolis extracts on Salmonella enterica, as well as to determine the content of bioactive compounds and the sensitivity profile to antimicrobials used in therapeutic use. A propolis was subjected to two types of extraction, ethanolic and ultrasonic, resulting from equal extractions of terminology. Total phenolic compounds, total flavonoid content and total antioxidant activity were quantified by the free radical DPPH. These extracts were diluted in ethanol in the applications: 100; 50; 25; 12.5; 6.25; 3.125; 1.56; 0.8; 0.4; 0.2 and 0.1 mg / mL-1. Two reference strains and 30 species of Salmonella genus processed by agricultural food and environment subsidized by cell viability tests using the microdilution method. Analyze the susceptibility profile of all strains for amikacin (30g), norfloxacin (10g), ceftriaxone (30g), ceftiofur (30g) and doxycycline (30g), using the disk-diffusion method. The results showed those that presented a studied and crossed resistance field, and 83.3% (25/30) of the samples were resistant to one or more antimicrobial agents used, only five times without resistance and 21 caused by multiresistants. Cross resistance occurred in 63.3% (19/30) of individuals facing cephalosporins. Regarding the action of ethanol extraction of green propolis, it was identified that the serotypes Agona, Anatum, Cerro, Saintpaul and all as strains of Schwarzengrund are the same or equal responses to minimal inhibition. To serovar, Heidelberg reduced the variability for MIC, using 6.25 to 25 mg / mL-1, as well as for the minimum bactericidal concentration with variations between 50 and 100 mg / mL-1. To extract ultrasound of green propolis from CIM, it presents equal responses for serotypes Agona, Cerro and Saintpaul. For Heidelberg serovar there was a variation for MIC between 6.25 to 25 mg / mL-1, for Schwarzengrund serovar there was a variation between 6.25 to 12.5 mg / mL-1. It is concluded that field isolates reinforce the alert about multidrug-resistant strains for antimicrobial bases chosen for therapeutic use in the context of animal and human health. The extracts of green propolis, due to their concentration of phenolic / flavonoid compounds and their antioxidant components, showed biological antimicrobial action that inhibited, in varying concentrations, Salmonella enterica serotypes from the poultry environment. For these observations, both extracts of green propolis can be considered as a dose-dependent alternative to Salmonella inhibition.

PROPOLIS E GEOPROPOLIS VERDE DO SEMIARIDO DO BRASIL: CARACTERIZAÇÃO QUIMICA, ORIGEM BOTANICA E ATIVIDADE ANTIOXIDANTE

Na região Nordeste do Brasil, estudos que objetivam identificar os compostos presentes nas própolis tem se expandido nos últimos anos. No entanto, até o presente momento, o conhecimento sobre própolis e geoprópolis da região de semiárido do Nordeste brasileiro é escasso. Para suprir essa necessidade, objetivou-se fazer uma investigação a respeito de um tipo de própolis e de geoprópolis, ambos de coloração verde, produzidos nessa região. Foram coletadas amostras de própolis e de geoprópolis no estado do Rio Grande do Norte, Brasil. Também foram coletados folíolos jovens e maduros de jurema-preta (Mimosa tenuiflora), principal suspeita de ser a fonte botânica dessas amostras. As amostras de própolis, geoprópolis e folíolos foram submetidas a extração etanólica em Soxhlet por 6 horas. Extratos das amostras de própolis e geoprópolis foram utilizados para avaliação de parâmetros básicos para comercialização de própolis no Brasil. Posteriormente, os extratos de própolis, geoprópolis e folíolos seguiram para análise em HPLC-DAD-MS/MS, onde foram quantificados e identificados os seus respectivos compostos fenólicos. Por fim, as amostras passaram por dois testes para identificação da origem botânica: 1) Comparação de compostos químicos presentes nos extratos dos folíolos de M. tenuiflora, própolis e geoprópolis. 2) Comparação microscópica dos tecidos vegetais de M. tenuiflora com os encontrados nas amostras de própolis e geoprópolis. Na avaliação dos parâmetros básicos para comercialização, as amostras de própolis e geoprópolis obtiveram valores aceitáveis conforme a legislação vigente, apresentando alta atividade antioxidante. Estas possuíam níveis de flavonoides totais acima do comum para própolis brasileiras (117 e 98,5 g/kg1, própolis e geoprópolis, respectivamente). Foram encontrados 18 compostos fenólicos nos extratos etanólicos de folíolos de M. tenuiflora e da própolis, na sua maioria flavonóis e chalconas. Desses, dez foram encontrados no extrato de geoprópolis verde, além de outros 6 compostos distintos. Na análise microscópica foram encontrados folíolos de M. tenuiflora, tanto na própolis como na geoprópolis. Também foi possível descrever algumas estruturas epidérmicas da planta e avaliar suas características particulares. Conclui-se que própolis e geoprópolis verdes do semiárido nordestino do Brasil possuem qualidade para comercialização, estando seus parâmetros dentro do indicado pela legislação, e que M. tenuiflora é a fonte botânica da própolis e geoprópolis verdes. Esse trabalho servirá como base para pesquisas futuras que visem a otimização da apicultura no semiárido brasileiro e preservação de espécies endêmicas importantes como M. tenuiflora.

Studies to identify compounds in propolis have been expanded in recent years in northeast Brazil. However, up to now knowledge about the description of propolis and geopropolis in the Brazilian semi-arid is scarce. The aim of this study was to investigate a type of propolis and a geopropolis, both in green color, produced in this region. Samples of propolis and geopropolis were collected in the state of Rio Grande do Norte, Brazil. Young and ripe shoot of jurema-preta (Mimosa tenuiflora) were also collected, as suspected to be the main botanical source of these samples. Propolis, geopropolis and shoot samples were submitted to ethanolic extraction in Soxhlet for 6 hours. Extracts of propolis and geopropolis samples were used to evaluate basic parameters for commercialization. In sequence, the extracts were analyzed in HPLC-DAD-MS/MS, for identification and quantification of their respective phenolic compounds. Finally, the samples underwent two tests to identify the botanical origin: 1) Comparison of chemical compounds in M. tenuiflora shoot, propolis and geopropolis extracts. 2) Microscopic comparison of M. tenuiflora plant tissues with those found in propolis and geopropolis samples. According to current legislation, propolis and geopropolis samples obtained acceptable evaluation for commercialization, presenting high antioxidant activity. The analysis showed above-normal total flavonoid levels for Brazilian propolis (117 and 98.5 g/kg, for propolis and geopropolis respectively). Eighteen phenolic compounds were found in the ethanolic extracts of M. tenuiflora shoot and propolis, mostly flavonols and chalcones. Ten of 18 were found in green geopropolis extract, plus 6 different compounds. In microscopic analysis several shoot of M. tenuiflora were found, both in propolis and in geopropolis. It was also possible to describe some epidermal structures of the plant and to evaluate some of its characteristics. This study concluded that green propolis and geopropolis of Caatinga semiarid biome are qualified for commercialization, with analytical parameters according to indicated legislation, and M. tenuiflora is the botanical source of green propolis and geopropolis of this semiarid biome. This study will guide future researches aiming to optimize beekeeping in Caatinga Brazilian semiarid and protect important endemic plant species as M. tenuiflora.